Grantham, Mayo, Van Otterloo & Co (GMO)’s Exela Technologies, Inc. Common Stock XELA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-25
Closed -$2.98M 661
2016
Q4
$2.98M Hold
25
0.02% 284
2016
Q3
$2.97M Hold
25
0.01% 298
2016
Q2
$2.97M Hold
25
0.01% 336
2016
Q1
$2.93M Hold
25
0.01% 340
2015
Q4
$2.91M Hold
25
0.01% 304
2015
Q3
$2.94M Hold
25
0.01% 287
2015
Q2
$2.96M Buy
+25
New +$2.95M 0.01% 303

Other funds holding XELA

Grantham, Mayo, Van Otterloo & Co (GMO)'s XELA Position: Q1 2017 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Exela Technologies, Inc. Common Stock (XELA) in Q1 2017, closing a stake of 25 shares — an estimated $2.98M sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in XELA in Q2 2015 and held it in 7 quarters. The position peaked at $2.98M in Q4 2016. 20 funds tracked by Wall St. Rank hold XELA as of Q1 2017.

  • Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Exela Technologies, Inc. Common Stock position as of Q1 2017 after selling out during the quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 25 Exela Technologies, Inc. Common Stock shares in Q1 2017, an estimated $2.98M.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Exela Technologies, Inc. Common Stock in Q2 2015 and held it in 7 quarters.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Exela Technologies, Inc. Common Stock position peaked at $2.98M in Q4 2016.
  • 20 funds tracked by Wall St. Rank held Exela Technologies, Inc. Common Stock as of Q1 2017.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q1 2017, filed 15 May 2017.